Biochimica et Biophysica Acta 2014-10-01

Structural dynamics and physicochemical properties of pDNA/DODAB:MO lipoplexes: effect of pH and anionic lipids in inverted non-lamellar phases versus lamellar phases.

J P Neves Silva, I M S C Oliveira, A C N Oliveira, M Lúcio, A C Gomes, P J G Coutinho, M E C D Real Oliveira

Index: Biochim. Biophys. Acta 1838(10) , 2555-67, (2014)

Full Text: HTML

Abstract

Dioctadecyldimethylammonium bromide (DODAB):Monoolein (MO) lipoplexes have mainly been studied within the range of high molar ratios of DODAB, with noticeable transfection efficiencies in the Human Embryonic Kidney (HEK, a.k.a. 293T) cell line. In this work, we intend to study the effect of high MO content on the structure and physicochemical properties of pDNA/DODAB:MO lipoplexes to achieve some correlation with their transfection efficiency. Static/Dynamic Light Scattering and Cryo-TEM imaging were used to characterize the size/morphology of DNA/DODAB:MO lipoplexes at different DODAB:MO contents (2:1, 1:1, 1:2) and charge ratios (CRs) (+/-). Nile Red fluorescence emission was performed to detect changes in microviscosity, hydration and polarity of DNA/DODAB:MO systems. Lipoplexes stability at physiological pH values and in the presence of anionic lipids was evaluated by Förster Resonance Energy Transfer (FRET). Physicochemical/structural data were complemented with transfection studies in HEK cells using the β-galactosidase reporter gene activity assay. This work reports the coexistence of multilamellar and non-lamellar inverted phases in MO-richer lipoplexes (DODAB:MO 1:2 and 1:4), leading to transfection efficiencies comparable to those of multilamellar (DODAB-richer) lipoplexes, but at higher charge ratios [CR (+/-)=6.0] and without dose-effect response. These results may be related to the structural changes of lipoplexes promoted by high MO content. Copyright © 2014 Elsevier B.V. All rights reserved.

Related Compounds

Structure Name/CAS No. Articles
Nile Red Structure Nile Red
CAS:7385-67-3
Levodopa Structure Levodopa
CAS:59-92-7
oleic acid Structure oleic acid
CAS:112-80-1
Dimethyldioctadecylammonium bromide Structure Dimethyldioctadecylammonium bromide
CAS:3700-67-2
Dicyclohexylcarbodiimide Structure Dicyclohexylcarbodiimide
CAS:538-75-0
DOPE Structure DOPE
CAS:4004-05-1
Glyceryl monooleate Structure Glyceryl monooleate
CAS:25496-72-4